Product Code: GVR-4-68040-121-4
Implantable Pacemaker Market Growth & Trends:
The global implantable pacemaker market size is anticipated to reach USD 3.8 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to grow at a lucrative CAGR of 3.7% from 2023 to 2030 owing to various factors such as technological advancements and the increasing prevalence of cardiovascular devices. Furthermore, the growing sedentary lifestyle coupled with the rising geriatric population is also anticipated to fuel the market growth during the projected period.
The increasing prevalence of cardiovascular diseases is a key growth driver for the market. Moreover, coronary heart disease accounts for the highest number of deaths, followed by stroke and heart failure. As per the British Heart Foundation Centre, nearly 7.6 million individuals are living with circulatory and heart diseases in the UK. Also, nearly 100,000 hospital admissions each year owing to heart attacks in the UK. To curb the rising prevalence of CVDs, government bodies, and key market players are channeling revenues to offer a potential treatment. This is anticipated by the influx of advanced products in this market space.
Technological developments are quickly renovating the pacemaker market. Heart disease is the major cause of death in recent years. According to World Health Organization (WHO) estimates, each year cardiovascular diseases (CVDs) result in around 17.9 million mortalities. CVDs are normally identified as a silent epidemic as they are slow to show symptoms. Moreover, they are projected to be one of the most expensive health conditions to treat. Thus, an increase in the usage of implantable pacemakers in cardiovascular diseases boosts the growth of the market.
Implantable Pacemaker Market Report Highlights:
- Based on product, the market is classified into single chamber, dual chamber, and biventricular chamber. Dual chamber segment held the largest revenue share of 38.9% of the market in 2022, due to the increase in demand for dual chamber implantable pacemakers
- Based on application, the market is categorized into arrhythmias, congestive heart failure, and others. The arrhythmias segment accounted for the largest share of the market in 2022 owing to the rise in prevalence of cardiac arrhythmia
- The end-use segment is divided into hospitals and outpatient facilities. The hospitals segment accounted for the largest share of the market in 2022 owing to the high number of surgeries performed in hospitals and the availability of skilled professionals
- The North American region is expected to dominate the market and hold the largest revenue share of over 40.2% in 2022, owing to the increasing incidence of cardiovascular diseases and a large patient population
- Asia Pacific is estimated to grow at the fastest rate during the forecast period due to the increasing investment in healthcare infrastructure in recent years, particularly in emerging economies such as China and India
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation and Scope
- 1.1.1 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.4.1 Commodity Flow Analysis (Model 1)
- 1.7 List of Secondary Sources
- 1.8 List of Primary Sources
- 1.9 Objectives
- 1.9.1 Objective 1
- 1.9.2 Objective 2
- 1.9.3 Objective 3
Chapter 2 Executive Summary
- 2.1 Market Snapshot
- 2.2 Segment Snapshot
- 2.3 Competitive Landscape Snapshot
Chapter 3 Implantable Pacemaker Market Variables, Trends, and Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
- 3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.1.1 Rising prevalence of cardiovascular diseases (CVD)
- 3.2.1.2 Favorable reimbursement policies
- 3.2.1.3 Technological advancements
- 3.2.2 Market Restraint Analysis
- 3.2.2.1 Stringent regulation and approvals
- 3.2.2.2 Product Recalls
- 3.3 Pacemaker: Market Analysis Tools
- 3.3.1 Industry Analysis - Porter's
- 3.3.2 SWOT Analysis By Factors (Political & Legal, Economic, Social And Technological)
- 3.4 Economic Impact Analysis
Chapter 4 Implantable Pacemaker Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)
- 4.1 Product Market Share Analysis, 2022 & 2030
- 4.2 Global Implantable Pacemaker Market, by Product, 2018 to 2030
- 4.2.1 Single Chamber
- 4.2.1.1 Single Chamber market, 2018 - 2030 (USD Million)
- 4.2.2 Dual Chamber
- 4.2.2.1 Dual Chamber market, 2018 - 2030 (USD Million)
- 4.2.3 Biventricular Chamber
- 4.2.3.1 Biventricular market, 2018 - 2030 (USD Million)
Chapter 5 Implantable Pacemaker Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
- 5.1 Application Market Share Analysis, 2022 & 2030
- 5.2 Global Implantable Pacemaker Market, by Application, 2018 to 2030
- 5.2.1 Arrhythmias
- 5.2.1.1 Arrhythmias market, 2018 - 2030 (USD Million)
- 5.2.1.2 Atrial Fibrillation
- 5.2.1.3 Heart Block
- 5.2.1.4 Long QT Syndrome
- 5.2.2 Congestive Heart Failure
- 5.2.2.1 Congestive Heart Failure market, 2018 - 2030 (USD Million)
- 5.2.3 Others
- 5.2.3.1 Others market, 2018 - 2030 (USD Million)
Chapter 6 Implantable Pacemaker Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
- 6.1 End Use Market Share Analysis, 2022 & 2030
- 6.2 Global Implantable Pacemaker Market, by End Use, 2018 to 2030
- 6.2.1 Hospitals
- 6.2.1.1 Hospitals market, 2018 - 2030 (USD Million)
- 6.2.2 Outpatient Facilities
- 6.2.2.1 Outpatient Facilities market, 2018 - 2030 (USD Million)
Chapter 7 Implantable Pacemaker Market: Regional Estimates & Trend Analysis, By Region, 2018 - 2030 (USD Million)
- 7.1 Regional Market Snapshot
- 7.2 North America
- 7.2.1 North America Market Estimates And Forecasts, By Country, 2018-2030 (USD Million)
- 7.2.2 U.S.
- 7.2.2.1 U.S. Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.2.3 Canada
- 7.2.3.1 Canada Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.3 Europe
- 7.3.1 Europe Implantable Pacemaker Market, By Country, 2018 - 2030 (USD Million)
- 7.3.2 UK
- 7.3.2.1 UK Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.3.3 Germany
- 7.3.3.1 Germany Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.3.4 France
- 7.3.4.1 France Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.3.5 Italy
- 7.3.5.1 Italy Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.3.6 Spain
- 7.3.6.1 Spain Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.3.7 Denmark
- 7.3.7.1 Denmark Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.3.8 Sweden
- 7.3.8.1 Sweden Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.3.9 Norway
- 7.3.9.1 Norway Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.4 Asia Pacific
- 7.4.1 Asia Pacific Implantable Pacemaker Market, By Country, 2018 - 2030 (USD Million)
- 7.4.2 Japan
- 7.4.2.1 Japan Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.4.3 China
- 7.4.3.1 China Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.4.4 India
- 7.4.4.1 India Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.4.5 Australia
- 7.4.5.1 Australia Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.4.6 South Korea
- 7.4.6.1 South Korea Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.4.7 Thailand
- 7.4.7.1 Thailand Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.5 Latin America
- 7.5.1 Latin America Implantable Pacemaker Market, By Country, 2018 - 2030 (USD Million)
- 7.5.2 Brazil
- 7.5.2.1 Brazil Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.5.3 Mexico
- 7.5.3.1 Mexico Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.5.4 Argentina
- 7.5.4.1 Argentina Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.6 MEA
- 7.6.1 MEA Implantable Pacemaker Market, By Country 2018 - 2030 (USD Million)
- 7.6.2 South Africa
- 7.6.2.1 South Africa Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.6.3 Saudi Arabia
- 7.6.3.1 Saudi Arabia Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.6.4 UAE
- 7.6.4.1 UAE Implantable Pacemaker Market, 2018 - 2030 (USD Million)
- 7.6.5 Kuwait
- 7.6.5.1 Kuwait Implantable Pacemaker Market, 2018 - 2030 (USD Million)
Chapter 8 Company Profile
- 8.1 Osypka Medical GmbH
- 8.1.1 Company Overview
- 8.1.2 Financial Performance
- 8.1.3 Product Benchmarking
- 8.1.4 Strategic Initiatives
- 8.2 Boston Scientific Corporation
- 8.2.1 Company Overview
- 8.2.2 Financial Performance
- 8.2.3 Product Benchmarking
- 8.2.4 Strategic Initiatives
- 8.3 Zoll Medical Corporation
- 8.3.1 Company Overview
- 8.3.2 Financial Performance
- 8.3.3 Product Benchmarking
- 8.3.4 Strategic Initiatives
- 8.4 Medtronic
- 8.4.1 Company Overview
- 8.4.2 Financial Performance
- 8.4.3 Product Benchmarking
- 8.4.4 Strategic Initiatives
- 8.5 BIOTRONIK
- 8.5.1 Company Overview
- 8.5.2 Financial Performance
- 8.5.3 Product Benchmarking
- 8.5.4 Strategic Initiatives
- 8.6 MicroPort Scientific Corporation
- 8.6.1 Company Overview
- 8.6.2 Financial Performance
- 8.6.3 Product Benchmarking
- 8.6.4 Strategic Initiatives
- 8.7 Cook Medical
- 8.7.1 Company Overview
- 8.7.2 Financial Performance
- 8.7.3 Product Benchmarking
- 8.7.4 Strategic Initiatives
- 8.8 MEDICO SpA
- 8.8.1 Company Overview
- 8.8.2 Financial Performance
- 8.8.3 Product Benchmarking
- 8.8.4 Strategic Initiatives
- 8.9 Pacetronix
- 8.9.1 Company Overview
- 8.9.2 Financial Performance
- 8.9.3 Product Benchmarking
- 8.9.4 Strategic Initiatives
- 8.10 Abbott
- 8.10.1 Company Overview
- 8.10.2 Financial Performance
- 8.10.3 Product Benchmarking
- 8.10.4 Strategic Initiatives